Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ellagic Acid and Glutathione

supplement:

Ellagic Acid

supplement:

Glutathione

Research Papers that Mention the Interaction

On the other hand, cotreatment with EA (25 and 50 μM) inhibited AA-induced oxidative stress which subsequently led to decreasing of the cytotoxicity, GSH oxidation, lipid peroxidation, MMP collapse, lysosomal and DNA damage.
PloS one  •  2021  |  View Paper
EA administration increased the protein expression levels of nuclear factor erythroid 2-related factor 2 (Nrf-2) and enhanced the activity of glutathione (GSH) and catalase enzyme (CAT).
Environmental Science and Pollution Research  •  2019  |  View Paper
Ellagic and/ ferulic acid significantly reduced the accumulation of As, protein carbonylation (PC), lipid peroxidation (LPO) in addition to altering the antioxidant enzymes (CAT and SOD) activities, reduced glutathione ( GSH ) and total antioxidant capacity (TAC) in the testicular tissues.
Toxicology  •  2019  |  View Paper
Treatment with EA enhanced the glutathione (GSH) content in liver (p<0.001) and up-regulated renal and hepatic superoxide dismutase (SOD) and glutathione peroxidase (GPx) mRNA expression (all p<0.001).
Pharmacological reports : PR  •  2018  |  View Paper
Furthermore, both the doses of EGA attenuated STZ-ICV induced rise in brain TBARS as well as TNF-α and simultaneously enhanced the GSH content.
Drug research  •  2017  |  View Paper
The toxic side effects in testis and bone marrow tissues were greatly ablated with a significant reduction in lipid peroxidation level and elevation in CAT and Px activities and glutathione concentration when using EA.
Ultrastructural pathology  •  2016  |  View Paper
The administration of ellagic acid to cisplatin-treated rats decreased the MDA levels, and increased GSH , GSH-Px and CAT in these samples.
Basic & clinical pharmacology & toxicology  •  2007  |  View Paper
While treatment of rats with VES alone or in combination with TCDD resulted in significant increases in SOD and CAT activities in different brain regions, treatment with EA resulted in a significant rise in total GSH levels and GSH-Px activity in those regions.
Journal of toxicology and environmental health. Part A  •  2006  |  View Paper
Both ellagic acid and QR caused a significant increase in GSH and decrease in NADPH- and ascorbate-dependent lipid peroxidation.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association  •  1999  |  View Paper
Feeding of EA significantly increased the levels of reduced glutathione and glutathione reductase in liver and lungs of male and female mice.
Biochemical pharmacology  •  1991  |  View Paper
Show More